These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8576482)

  • 1. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients.
    Stillman AE; Wilke N; Li D; Haacke M; McLachlan S
    J Comput Assist Tomogr; 1996; 20(1):51-5. PubMed ID: 8576482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan (NC100150 injection) in patients with coronary artery disease.
    Klein C; Schalla S; Schnackenburg B; Bornstedt A; Hoffmann V; Fleck E; Nagel E
    J Magn Reson Imaging; 2003 Jun; 17(6):656-62. PubMed ID: 12766894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced 3D-TOF MRA of peripheral vessels: intravascular versus extracellular MR contrast media.
    Engelbrecht MR; Saeed M; Wendland MF; Canet E; Oksendal AN; Higgins CB
    J Magn Reson Imaging; 1998; 8(3):616-21. PubMed ID: 9626876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multislice breath-hold spiral magnetic resonance coronary angiography in patients with coronary artery disease: effect of intravascular contrast medium.
    Knuesel PR; Nanz D; Wolfensberger U; Saranathan M; Lehning A; Luescher TF; Marincek B; von Schulthess GK; Schwitter J
    J Magn Reson Imaging; 2002 Dec; 16(6):660-7. PubMed ID: 12451579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla.
    Allkemper T; Heindel W; Kooijman H; Ebert W; Tombach B
    Invest Radiol; 2006 Feb; 41(2):97-104. PubMed ID: 16428979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
    Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
    Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography.
    Taylor AM; Panting JR; Keegan J; Gatehouse PD; Amin D; Jhooti P; Yang GZ; McGill S; Burman ED; Francis JM; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Feb; 9(2):220-7. PubMed ID: 10077017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breath-hold 3D MR coronary angiography with a new intravascular contrast agent (feruglose)--first clinical experiences.
    Sandstede JJ; Pabst T; Wacker C; Wiesmann F; Hoffmann V; Beer M; Kenn W; Bauer W; Hahn D
    Magn Reson Imaging; 2001 Feb; 19(2):201-5. PubMed ID: 11358658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
    Bremer C; Allkemper T; Baermig J; Reimer P
    J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbits.
    Loubeyre P; Zhao S; Canet E; Abidi H; Benderbous S; Revel D
    J Magn Reson Imaging; 1997; 7(6):958-62. PubMed ID: 9400837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
    Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
    Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary arteries at 3.0 T: Contrast-enhanced magnetization-prepared three-dimensional breathhold MR angiography.
    Bi X; Li D
    J Magn Reson Imaging; 2005 Feb; 21(2):133-9. PubMed ID: 15666400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spiral coronary angiography using a blood pool agent.
    Ringgaard S; Pedersen M; Rickers J; Johansson LO; Börnert P; Pedersen EM
    J Magn Reson Imaging; 2005 Aug; 22(2):213-8. PubMed ID: 16028253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved three-dimensional free-breathing coronary magnetic resonance angiography using gadocoletic acid (B-22956) for intravascular contrast enhancement.
    Paetsch I; Huber ME; Bornstedt A; Schnackenburg B; Boesiger P; Stuber M; Fleck E; Cavagna F; Nagel E
    J Magn Reson Imaging; 2004 Aug; 20(2):288-93. PubMed ID: 15269955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPIO-enhanced 2D-TOF MR angiography of the portal venous system: results of an intraindividual comparison.
    Reimer P; Marx C; Rummeny EJ; Müller M; Lentschig M; Balzer T; Dietl KH; Sulkowski U; Berns T; Shamsi K; Peters PE
    J Magn Reson Imaging; 1997; 7(6):945-9. PubMed ID: 9400835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extremely Small Pseudoparamagnetic Iron Oxide Nanoparticle as a Novel Blood Pool T1 Magnetic Resonance Contrast Agent for 3 T Whole-Heart Coronary Angiography in Canines: Comparison With Gadoterate Meglumine.
    Park EA; Lee W; So YH; Lee YS; Jeon BS; Choi KS; Kim EG; Myeong WJ
    Invest Radiol; 2017 Feb; 52(2):128-133. PubMed ID: 27977466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
    Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
    J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-enhanced versus low-dose contrast-enhanced renal magnetic resonance angiography at 7 T: a feasibility study.
    Laader A; Beiderwellen K; Kraff O; Maderwald S; Ladd ME; Forsting M; Umutlu L
    Acta Radiol; 2018 Mar; 59(3):296-304. PubMed ID: 28691526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits.
    Allkemper T; Bremer C; Matuszewski L; Ebert W; Reimer P
    Radiology; 2002 May; 223(2):432-8. PubMed ID: 11997549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.